Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|4|577-586

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.4, 2015-03, pp. : 577-586

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 5, 2015-12 ,pp. : 476-480

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone

By Silverstein Melvin J  

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 565-577

Future Medicine

Access to resources Recommend Favorite

Breast cancer risk associated with atypical hyperplasia and lobular carcinoma in situ initially diagnosed on core‐needle biopsy

By  

CANCER, Vol. 124, Iss. 3, 2018-02 ,pp. : 459-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ductal Carcinoma in situ of the Breast: Diagnosis and Management

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 588-595

Karger

Access to resources Recommend Favorite

Risk of recurrence of ductal carcinoma in situ by oncotype Dx technology: Some concerns

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1085-1085

John Wiley & Sons Inc

Access to resources Recommend Favorite